Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Clinical trial NCT06005259 · UNKNOWN
Trial details
- NCT number
- NCT06005259
- Sponsor
- University of Sao Paulo
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2025-10-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.